A 5-hydroxymethylcytosine-based noninvasive model for acute myocardial infarction in type 2 diabetes: implications in cardiovascular outcomes from a 5-year median follow-up study

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Cardiovascular Diabetology

• Publication date

  2026-01-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1186/s12933-026-03087-2PMID 41618335PMCID PMC12934080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA methylation predicts adverse outcomes of coronary artery disease

  2025cited by this paper
• Exploring the Role of Cardiac Troponin-Specific Autoantibodies: Prolonged Cardiac Troponin Elimination, Reduced Clearance, and Variable Interference across 5 Commercial Assays.

  2025cited by this paper
• Possible Misdiagnosis of Myocardial Infarction Using Regulatory‐Approved and Close‐to‐Bioequivalent Upper Limits of Normal for Cardiac Troponin

  2025cited by this paper
• Incident heart failure and recurrent coronary events following acute myocardial infarction

  2025cited by this paper
• Organ-specific biological clocks: ageotyping for personalized anti-aging medicine.

  2024cited by this paper
• A 5-hydroxymethylcytosine-based non-invasive model for early detection of colorectal carcinomas and advanced adenomas: the METHOD-2 study.

  2024cited by this paper
• Comprehensive echocardiographic and biomarker assessment of patients with diabetic ketoacidosis

  2024cited by this paper
• Risk prediction of cardiovascular disease in the Asia-Pacific region: the SCORE2 Asia-Pacific model

  2024cited by this paper
• DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes

  2024cited by this paper
• Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer’s Disease

  2023cited by this paper
• Macrophage CARD9 mediates cardiac injury following myocardial infarction through regulation of lipocalin 2 expression

  2023cited by this paper
• 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.

  2023cited by this paper
• PETCH-DB: a Portal for Exploring Tissue-specific and Complex disease-associated 5-Hydroxymethylcytosines

  2023cited by this paper
• Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

  2023influential reference
• Cellular Composition and 5hmC Signature Predict the Treatment Response of AML Patients to Azacitidine Combined with Chemotherapy

  2023cited by this paper
• SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe

  2023cited by this paper
• Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention

  2023cited by this paper
• N 6‐methyladenine profiling of low‐input multiplex clinical samples on transcriptome reveals RNA modifications implicated in type 2 diabetes and acute myocardial infarction

  2023cited by this paper
• 5-Hydroxymethylcytosine profiles in plasma cell-free DNA reflect molecular characteristics of diabetic kidney disease

  2022cited by this paper
• Noninvasive detection of brain gliomas using plasma cell‐free DNA 5‐hydroxymethylcytosine sequencing

  2022cited by this paper
• Development of an interpretable machine learning model associated with heavy metals' exposure to identify coronary heart disease among US adults via SHAP: Findings of the US NHANES from 2003 to 2018.

  2022cited by this paper
• Molecular and cellular pathophysiology of circulating cardiomyocyte-specific cell free DNA (cfDNA): Biomarkers of heart failure and potential therapeutic targets

  2022cited by this paper
• Mitochondrial MICOS complex genes, implicated in hypoplastic left heart syndrome, maintain cardiac contractility and actomyosin integrity

  2022cited by this paper
• The cell type specific 5hmC landscape and dynamics of healthy human hematopoiesis and TET2-mutant pre-leukemia.

  2022cited by this paper
• Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association

  2022cited by this paper
• SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.

  2021cited by this paper
• SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.

  2021cited by this paper
• clusterProfiler 4.0: A universal enrichment tool for interpreting omics data

  2021influential reference
• SHAP and LIME: An Evaluation of Discriminative Power in Credit Risk

  2021cited by this paper
• 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

  2021cited by this paper
• OUP accepted manuscript

  2021cited by this paper
• Natural killer cell-derived exosomal miR-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes

  2021cited by this paper
• Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

  2021cited by this paper
• SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease

  2020cited by this paper
• A human tissue map of 5-hydroxymethylcytosines exhibits tissue specificity through gene and enhancer modulation

  2020cited by this paper
• 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic and predictive biomarkers for coronary artery disease

  2020cited by this paper
• OUTCOMES OF CHRONIC TOTAL OCCLUSION PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE

  2020cited by this paper
• Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood

  2019cited by this paper
• 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.

  2019cited by this paper
• 5-Hydroxymethylcytosines in Circulating Cell-Free DNA Reveal Vascular Complications of Type 2 Diabetes.

  2019cited by this paper
• The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway.

  2019cited by this paper
• Fourth Universal Definition of Myocardial Infarction (2018).

  2018cited by this paper
• The Transcription Factor ETV1 Induces Atrial Remodeling and Arrhythmia

  2018cited by this paper
• The diverse origins of circulating cell‐free DNA in the human body: a critical re‐evaluation of the literature

  2018cited by this paper
• Standards of Medical Care in Diabetes-2017: Summary of Revisions.

  2017cited by this paper
• 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers

  2017cited by this paper
• Comprehensive evaluation of genome-wide 5-hydroxymethylcytosine profiling approaches in human DNA

  2017cited by this paper
• Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Diabetes: Insights From the OPEN CTO Registry.

  2017cited by this paper
• Extracellular histones, cell-free DNA, or nucleosomes: differences in immunostimulation

  2016cited by this paper
• A Highly Sensitive and Robust Method for Genome-wide 5hmC Profiling of Rare Cell Populations.

  2016cited by this paper
• Standards of Medical Care in Diabetes—2017: Summary of Revisions

  2016cited by this paper
• DNA hydroxymethylation controls cardiomyocyte gene expression in development and hypertrophy

  2016cited by this paper
• Epigenetics and Cardiovascular Disease in Diabetes

  2015cited by this paper
• Robust enumeration of cell subsets from tissue expression profiles

  2015cited by this paper
• Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

  2014cited by this paper
• Peroxidasin-like protein: a novel peroxidase homologue in the human heart.

  2014cited by this paper
• Trimmomatic: a flexible trimmer for Illumina sequence data

  2014cited by this paper
• featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

  2013cited by this paper
• Fast gapped-read alignment with Bowtie 2

  2012cited by this paper
• KEGG for integration and interpretation of large-scale molecular data sets

  2011influential reference
• Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine

  2011cited by this paper
• MICE: Multivariate Imputation by Chained Equations in R

  2011cited by this paper
• Regularization Paths for Generalized Linear Models via Coordinate Descent.

  2010cited by this paper
• The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain

  2009cited by this paper
• Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke.

  2009cited by this paper
• Adjusting batch effects in microarray expression data using empirical Bayes methods.

  2007cited by this paper
• Assessing kidney function--measured and estimated glomerular filtration rate.

  2006cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005cited by this paper
• Random Forests

  2001cited by this paper
• The Cox Model

  2000cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995cited by this paper

• No citing papers are available for this paper.